
Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (4)
- (-) Exascale Computing (3)
- 3-D Printing/Advanced Manufacturing (2)
- Advanced Reactors (2)
- Artificial Intelligence (35)
- Big Data (1)
- Bioenergy (2)
- Biology (4)
- Chemical Sciences (2)
- Computer Science (18)
- Coronavirus (1)
- Fossil Energy (2)
- Frontier (5)
- Fusion (2)
- Grid (2)
- High-Performance Computing (7)
- Isotopes (1)
- Machine Learning (8)
- Materials (1)
- Materials Science (3)
- Mathematics (1)
- Microscopy (1)
- Nanotechnology (1)
- National Security (5)
- Neutron Science (3)
- Quantum Science (1)
- Security (1)
- Simulation (1)
- Summit (3)
Media Contacts

Prasanna Balprakash, director of AI programs for ORNL, discussed advancing climate and weather research through high performance computing and artificial intelligence as part of a September 18 panel for the United States Senate.

A team led by researchers at ORNL explored training strategies for one of the largest artificial intelligence models to date with help from the world’s fastest supercomputer. The findings could help guide training for a new generation of AI models for scientific research.

In summer 2023, ORNL's Prasanna Balaprakash was invited to speak at a roundtable discussion focused on the importance of academic artificial intelligence research and development hosted by the White House Office of Science and Technology Policy and the U.S. National Science Foundation.

Scientists at ORNL used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.

The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.

OAK RIDGE, Tenn., March 4, 2019—A team of researchers from the Department of Energy’s Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials.